ChitoTech was developed from a research facility for the study of natural biopolymers and their applications in medicine. The manufacturing site of the company was established in 2004. It is the first company in the Middle East producing antiseptic solutions based on nanosilver, advanced wound care and hemostatic products. All ChitoTech products have the approval of Ministry of Health as well as CE, ISO13485, ISO 9001 certificates. Our biological wound care have patents from Denmark, France, Germany, Ireland (No1246650) and from England (No GB2358354). ChitoTech wound care products are suitable for a wide range of ulcers and burn wounds. Hemostatic products of ChitoTech are in different forms and are suitable for stopping venous and arterial bleedings.